Stock LTRN LANTERN PHARMA INC.
Add to a list
To use this feature you must be a member
Log inSign up

Insiders Lantern Pharma Inc.

Equities

LTRN

US51654W1018

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-12 pm EDT 		5-day change 1st Jan Change
4.42 USD +5.24% Intraday chart for Lantern Pharma Inc. +0.91% +3.27%
Jul. 10 Lantern Pharma Achieves Key Milestone Towards Development of Molecular Diagnostic for Use in Oncology Clinical Trials for Patient Selection and Stratification with Drug Candidate LP-184 CI
Jul. 01 Lantern Pharma Inc.(NasdaqCM:LTRN) dropped from Russell Microcap Value Index CI

Insiders

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Lantern Pharma Inc. Announces the Death of Dr. Franklyn Prendergast, a Director of the Company
CI
Lantern Pharma Inc. Appoints Ernest Kitt as Head of Clinical Operations
CI
Insider Sell: Lantern Pharma
MT
Lantern Pharma Inc. Announces Leslie W. Kreis, Jr. Not to Stand for Reelection as A Director
CI
Lantern Pharma Appoints Harry Kochat as Senior Director of Chemistry, Manufacturing and Controls and Manufacturing Quality Affair
CI
Lantern Pharma Inc. Announces Executive Changes
CI
Lantern Pharma Announces Board Appointments
CI
Lantern Pharma Inc. Appoints Jeff Keyser to its Board of Directors
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LTRN Stock
  4. News Lantern Pharma Inc.
  5. Insiders